Common Stock, Value, Issued of LakeShore Biopharma Co., Ltd. from 31 Mar 2022 to 31 Mar 2025

Taxonomy & unit: us-gaap: USD and CNY
Description: Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Summary: LakeShore Biopharma Co., Ltd. quarterly Common Stock, Value, Issued in USD history and change rate from 31 Mar 2022 to 31 Mar 2025.
LakeShore Biopharma Co., Ltd. Common Stock, Value, Issued for the quarter ending 31 Mar 2025 was $3,985, a 8.3% increase year-over-year.
LakeShore Biopharma Co., Ltd. quarterly Common Stock, Value, Issued in CNY history and change rate from 31 Mar 2022 to 31 Mar 2025.
LakeShore Biopharma Co., Ltd. Common Stock, Value, Issued for the quarter ending 31 Mar 2025 was ¥28,603, a 9.6% increase year-over-year.
Source SEC data: View on sec.gov

Common Stock, Value, Issued, Quarterly (USD)

Common Stock, Value, Issued, YoY Quarterly Change (%)

Common Stock, Value, Issued, Quarterly (CNY)

Common Stock, Value, Issued, YoY Quarterly Change (%)

LakeShore Biopharma Co., Ltd. Quarterly Common Stock, Value, Issued (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	$3,985	+$306	+8.3%	31 Mar 2025	20-F	31 Jul 2025	2025	FY
Q1 2024	$3,679	+$1,889	+106%	31 Mar 2024	20-F	15 Aug 2024	2024	FY
Q1 2023	$1,790			31 Mar 2023	20-F	26 Jul 2023	2023	FY

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	¥28,603	+¥2,498	+9.6%	31 Mar 2025	20-F	31 Jul 2025	2025	FY
Q1 2024	¥26,105	+¥13,808	+112%	31 Mar 2024	20-F	31 Jul 2025	2025	FY
Q1 2023	¥12,297	+¥4,319	+54%	31 Mar 2023	20-F	15 Aug 2024	2024	FY
Q1 2022	¥7,978			31 Mar 2022	20-F	26 Jul 2023	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.